Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05816850 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial

Study acronym: FIL_FOLL-BIO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 1, 2025 to Dec 1, 2026
    • Study completion date: Jun 1, 2026 to Jun 1, 2027
    v6
  2. Primary completion date: Jun 1, 2025 to Dec 1, 2025
    • Site details revised at 9 of 26 sites
    v5
  3. Site details revised at 4 of 26 sitesv4
  4. Primary completion date: Jun 1, 2024 to Jun 1, 2025
    • Site details revised at 4 of 26 sites
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 1, 2023 to Sep 19, 2023
    • Site details revised at 26 of 26 sites
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Multicenter, Retrospective, Biological study ancillary to FOLL12 trial to evaluate the role of EZH2 aberrations in patient with FL treated with immunochemotherapy. Moreover, several novel biomarkers of FL will be investigated.
Trial Details
NCT Number NCT05816850
Lead Sponsor Fondazione Italiana Linfomi - ETS
Conditions
(from sponsor)		 Follicular Lymphoma
Related terms Lymphoma, Lymphoma, Follicular
Enrollment 654 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov